Compound Summary
17318-31-9
Compound Information
17318-31-9
Compound Name: | 17318-31-9 |
Compound CID: | 5270 |
Synonyms: | 17318-31-9 9-(tetrahydrofuran-2-yl)-9h-purin-6-amine SQ22536 SQ 22536 Sq 22,536 More... |
Iupac Name: | 9-(oxolan-2-yl)purin-6-amine |
InChI: | InChI=1S/C9H11N5O/c10-8-7-9(12-4-11-8)14(5-13-7)6-2-1-3-15-6/h4-6H,1-3H2,(H2,10,11,12) |
InChIKey: | UKHMZCMKHPHFOT-UHFFFAOYSA-N |
Canonical Smiles: | C1CC(OC1)N2C=NC3=C(N=CN=C32)N |
Isomeric Smiles: | C1CC(OC1)N2C=NC3=C(N=CN=C32)N |
Molecular Weight: | 205.22 |
Molecular Formula: | C9H11N5O |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
17318-31-9
Molecular Weight: | 205.22 |
Molecular Formula: | C9H11N5O |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 1 |
Heavy Atom Count: | 15 |
Complexity: | 239 |
Synonyms
17318-31-9
| 17318-31-9 | 17318-31-9 |
|---|---|
17318-31-9 |
9-(tetrahydrofuran-2-yl)-9h-purin-6-amine |
SQ22536 |
SQ 22536 |
Sq 22,536 |
9-(Tetrahydro-2-furanyl)-9H-purin-6-amine |
9-(Tetrahydrofuryl)adenine |
SQ-22536 |
9-THF-Ade |
9H-Purin-6-amine, 9-(tetrahydro-2-furanyl)- |
6-Amino-9-(tetrahydro-2-furyl)-9H-purine |
CHEMBL64239 |
MLS002667588 |
CHEBI:90232 |
9H-Purin-6-amine,9-(tetrahydro-2-furanyl)- |
MFCD00210216 |
Adenine, 9-(tetrahydro-2-furyl)- |
AX 100 |
SMR001230661 |
Adenine, 9-(tetrahydro-2-furanyl)- |
9-(Tetrahydro-2′-furyl)adenine |
9-(OXOLAN-2-YL)-9H-PURIN-6-AMINE |
9-(Tetrahydrofuryl)-Adenine |
Lopac0_001192 |
BSPBio_001142 |
KBioGR_000482 |
KBioSS_000482 |
MLS002153167 |
SCHEMBL896095 |
9-(Tetrahydro-2-furyl)adenine |
BCBcMAP01_000102 |
KBio2_000482 |
KBio2_003050 |
KBio2_005618 |
KBio3_000883 |
KBio3_000884 |
Bio2_000411 |
Bio2_000891 |
HMS1362J03 |
HMS1792J03 |
HMS1990J03 |
HMS2235P22 |
HMS3263P05 |
HMS3266A19 |
HMS3369D08 |
HMS3403J03 |
HMS3412B05 |
HMS3676B05 |
BCP28072 |
EX-A1263 |
NSC53339 |
Tox21_501192 |
BDBM50009687 |
HSCI1_000170 |
NSC-53339 |
s8283 |
AKOS015998755 |
CCG-205266 |
CS-6136 |
FS-6588 |
LP01192 |
SDCCGSBI-0051159.P002 |
IDI1_002166 |
NCGC00015912-02 |
NCGC00015912-03 |
NCGC00015912-04 |
NCGC00015912-05 |
NCGC00015912-06 |
NCGC00015912-07 |
NCGC00015912-12 |
NCGC00094445-01 |
NCGC00094445-02 |
NCGC00094445-03 |
NCGC00094445-04 |
NCGC00094445-05 |
NCGC00261877-01 |
AC-32734 |
AB0022835 |
HY-100396 |
AM20210049 |
EU-0101192 |
FT-0688572 |
S-153 |
W3775 |
SQ 22,536, >=97% (HPLC), powder |
M02495 |
P10102 |
9-(Tetrahydro-furan-2-yl)-9H-purin-6-ylamine |
A881804 |
SR-01000075521 |
J-010883 |
SR-01000075521-1 |
BRD-A56987319-001-03-8 |
BRD-A56987319-001-05-3 |
Q27162414 |
SQ 22536 - CAS 17318-31-9 |
SQ22536; SQ 22536; SQ-22,536; SQ22,536; SQ 22,536 |
Experimental Data
17318-31-9
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 4.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
17318-31-9
Statistics Data
17318-31-9
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 4.000000000000000 | 1 | 1 |
Statistics Data Visualization
17318-31-9
